Mesoblast financial results and corporate update webcast

New york, feb. 25, 2025 (globe newswire) -- mesoblast limited (nasdaq:meso; asx:msb), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the half year ended december 31, 2024.
MESO Ratings Summary
MESO Quant Ranking